GRGDSP (TFA)

GRGDSP (TFA) is an integrin inhibitor.

Product Specifications

UNSPSC

12352209

Target

Integrin

Type

Peptides

Related Pathways

Cytoskeleton

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/GRGDSP_TFA.html

Purity

98.0

Solubility

H2O : 125 mg/mL (ultrasonic)

Smiles

O=C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N1[C@@H](CCC1)C(O)=O)=O)=O)=O)=O)CN.FC(C(O)=O)(F)F

Molecular Formula

C24H38F3N9O12

Molecular Weight

701.61

References & Citations

[1]Qian J, et al. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World J Gastroenterol. 2016 Jun 7;22 (21) :5042-9.|[2]Patel S, et al. Regulation of endothelial cell function by GRGDSP peptide grafted on interpenetrating polymers. J Biomed Mater Res A. 2007 Nov;83 (2) :423-33.